Evidence map›Paper›PMID 34068207›Full record

ArticleMaterials (Basel, Switzerland)2021

Synthesis and Characterization of Electrospun Composite Scaffolds Based on Chitosan-Carboxylated Graphene Oxide with Potential Biomedical Applications.

Elena Cojocaru, Jana Ghitman, Elena Iuliana Biru, Gratiela Gradisteanu Pircalabioru, Eugeniu Vasile, Horia Iovu

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Graphene and its Derivatives for Bone Tissue Engineering:Frontiers in bioengineering and biotechnology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Elena CojocaruAdvanced Polymer Materials Group, University Politehnica of Bucharest, 1-7 Polizu, 011061 Bucharest, Romania.ORCID 0000-0001-7783-7210
Jana GhitmanAdvanced Polymer Materials Group, University Politehnica of Bucharest, 1-7 Polizu, 011061 Bucharest, Romania.
Elena Iuliana BiruAdvanced Polymer Materials Group, University Politehnica of Bucharest, 1-7 Polizu, 011061 Bucharest, Romania.
Gratiela Gradisteanu PircalabioruResearch Institute of the University of Bucharest (ICUB), University of Bucharest, 91-95 Splaiul Independentei, 050095 Bucharest, Romania.
Eugeniu VasileDepartment of Science and Engineering of Oxide Materials and Nanomaterials, Faculty of Applied Chemistry and Material Science, University Politehnica of Bucharest, 1-7 Polizu, 011061 Bucharest, Romania.
Horia IovuAdvanced Polymer Materials Group, University Politehnica of Bucharest, 1-7 Polizu, 011061 Bucharest, Romania.

Funding

European Regional Development Fund through Competitiveness Operational Program 2014-2020, Priority axis 1 107066
6 · The paper itself

Abstract

This research study reports the development of chitosan/carboxylated graphene oxide (CS/GO-COOH) composite scaffolds with nanofibrous architecture using the electrospinning method. The concept of designed composite fibrous material is based on bringing together the biological properties of CS, mechanical, electrical, and biological characteristics of GO-COOH with the versatility and efficiency of ultra-modern electrospinning techniques. Three different concentrations of GO-COOH were added into a chitosan (CS)-poly(ethylene oxide) (PEO) solution (the ratio between CS/PEO was 3/7 (

Indexed as

carboxyl-modified graphene oxidecellular viabilitychitosancomposite scaffoldsnanofibrous architecture

Identifiers

PMID34068207
PMCPMC8153126

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.